Performance of the 13C-urea breath test for the diagnosis of H. pylori infection using a substrate synthesized in Brazil: A preliminary study

Coelho, Luiz Gonzaga; Sant'Ana, Carlos Roberto; Oliveira, Ricardo Brandt de; Cezar, Raíra César e; Araujo, Aline Cordeiro Campos de; Silva, Raisa Cristina Teodoro da; Trindade, Osmar Reni; Coelho, Maria Clara; Ferrioli, Eduardo; Bendassolli, José Albertino.
Clinics ; 73: e16553, 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-952792

Documentos relacionados

  1. Performance of the 13C-urea breath test for the diagnosis of H. pylori infection using a substrate synthesized in Brazil: A preliminary study.
  2. Synthesis of C-13-labeled atrazine.
  3. Regioselective syntheses of [13C]4-labelled sodium 1-carboxy-2-(2-ethylhexyloxycarbonyl)ethanesulfonate and sodium 2-carboxy-1-(2-ethylhexyloxycarbonyl)ethanesulfonate from [13C]4-maleic anhydride.
  4. Optimization of <sup>13</sup> C-urea breath test threshold levels for the detection of Helicobacter pylori infection in a national referral laboratory.
  5. Natural <sup>18</sup>O and <sup>13</sup>C-urea in gastric juice: a new route for non-invasive detection of ulcers.
  6. Application of citric acid can enhance the accuracy for <sup>13</sup>C-urea breath tests in the diagnosis of Helicobacter pylori infection in Chinese patients.
  7. Evaluation of urea breath test as a diagnostic tool for <i>Helicobacter pylori</i> infection in adult dyspeptic patients.
  8. An alternative and robust synthesis of [(13) C4 ]Baraclude® (entecavir).
  9. Large-scale preparation of (13) C-labeled 2-(phenylthio)acetic acid and the corresponding labeled sulfoxides and sulfones.
  10. Changes in urinary stable nitrogen isotope ratios during controlled short-term energy deficit: a proof-of-principle analysis.